Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy

Acta Oncologica

Volumn 54, Issue 10, 2015, Pages 1805-1813

  Nilsen, Tormod S ^a   Raastad, Truls ^a   Skovlund, Eva ^b   Courneya, Kerry S ^c   Langberg, Carl W ^d   Lilleby, Wolfgang ^d   Fosså, Sophie D ^d   Thorsen, Lene ^d  

^a NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF ALBERTA   (Canada)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GOSERELIN; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARM; ARTICLE; BODY COMPOSITION; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RESISTANCE TRAINING; WALKING; EXERCISE TEST; LOWER LIMB; MIDDLE AGED; MUSCLE STRENGTH; OBESITY; PATIENT COMPLIANCE; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UPPER LIMB;

ABSORPTIOMETRY, PHOTON; ADIPOSITY; AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; BODY COMPOSITION; BONE DENSITY; EXERCISE TEST; GOSERELIN; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MUSCLE STRENGTH; PATIENT COMPLIANCE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RESISTANCE TRAINING; SURVEYS AND QUESTIONNAIRES; UPPER EXTREMITY; WALKING;

EID: 84946221239     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2015.1037008     Document Type: Article

References (25)

1. Bolla M, Van Tienhoven G, Warde P, Dubois JB, Mirimanoff RO, Storme G, et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol 2010; 11: 1066-73.
2. Boxer RS, Kenny AM, Taxel P. The effect of 6 months of androgen deprivation therapy on muscle and fat mass in men with prostate cancer. J Am Geriatr Soc 2005; 53: S71-2.
3. van Londen GJ, Levy ME, Perera S, Nelson JB, Greenspan SL. Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study. Crit Rev Oncol Hematol 2008; 68: 172-7.
4. Haseen F, Murray LJ, Cardwell CR, OSullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis. J Cancer Survivor Res Pract 2010; 4: 128-39.
5. Tsang DS, Alibhai SM. Bone health care for patients with prostate cancer receiving androgen deprivation therapy. Hosp Pract 2014; 42: 89-102.
6. Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: A systematic review. J Clin Oncol 2014; 32: 335-46.
7. Galvão DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 2006; 38: 2045-52.
8. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. J Clin Oncol 2010; 28: 340-7.
9. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21: 1653-9.
10. Winters-Stone KM, Beer TM. Review of exercise studies in prostate cancer survivors receiving androgen deprivation therapy calls for an aggressive research agenda to generate high-quality evidence and guidance for exercise as standard of care. J Clin Oncol 2014; 32: 2518-9.
11. Kadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: Effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol 2000; 113: 25-9.
12. Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fossa SD. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: Rationale and design. BMC Cancer 2012; 12: 123.
13. DAmico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21: 2163-72.
14. Simmonds MJ. Physical function in patients with cancer: Psychometric characteristics and clinical usefulness of a physical performance test battery. J Pain Symptom Manage 2002; 24: 404-14.
15. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
16. Kvorning T, Andersen M, Brixen K, Madsen K. Suppression of endogenous testosterone production attenuates the response to strength training: A randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab 2006; 291: E1325-32.
17. Cormie P, Galvao DA, Spry N, Joseph D, Chee R, Taaffe DR, et al. Can supervised exercise prevent treatment toxicity in prostate cancer patients initiating androgen deprivation therapy: A randomised controlled trial. Br J Urol Int 2015; 115: 256-66.
18. Hanson ED, Sheaff AK, Sood S, Ma L, Francis JD, Goldberg AP, et al. Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy. J Gerontol A Biol Sci Med Sci 2013; 68: 490-8.
19. Trost LW, Serefoglu E, Gokce A, Linder BJ, Sartor AO, Hellstrom WJ. Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement. J Sex Med 2013; 10 (Suppl 1): 84-101.
20. Gomez-Cabello A, Ara I, Gonzalez-Aguero A, Casajus JA, Vicente-Rodriguez G. Effects of training on bone mass in older adults: A systematic review. Sports Med 2012; 42: 301-25.
21. Winters-Stone KM, Dobek JC, Bennett JA, Maddalozzo GF, Ryan CW, Beer TM. Skeletal response to resistance and impact training in prostate cancer survivors. Med Sci Sports Exerc 2014; 46: 1482-8.
22. Dobek J, Winters-Stone KM, Bennett JA, Nail L. Musculoskeletal changes after 1 year of exercise in older breast cancer survivors. J Cancer Survivor Res Pract 2014; 8: 304-11.
23. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, PrudHomme DG, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009; 27: 344-51.
24. Bolla M, de Reijke TM, Van Tienhoven G, Van den Bergh AC, Oddens J, Poortmans PM, et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 2009; 360: 2516-27.
25. Kalter J, Buffart LM, Korstjens I, van Weert E, Brug J, Verdonck-de Leeuw IM, et al. Moderators of the effects of group-based physical exercise on cancer survivors quality of life. Support Care Cancer Epub 2015 Feb 14.